The estimated Net Worth of John W. V Umstead is at least $1.4 millió dollars as of 5 July 2024. John Umstead owns over 527 units of G1 Therapeutics Inc stock worth over $1,338,429 and over the last 2 years John sold GTHX stock worth over $62,434.
John has made over 4 trades of the G1 Therapeutics Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently John sold 527 units of GTHX stock worth $1,323 on 5 July 2024.
The largest trade John's ever made was selling 8,151 units of G1 Therapeutics Inc stock on 13 May 2024 worth over $39,043. On average, John trades about 1,996 units every 23 days since 2023. As of 5 July 2024 John still owns at least 187,718 units of G1 Therapeutics Inc stock.
You can see the complete history of John Umstead stock trades at the bottom of the page.
John's mailing address filed with the SEC is 700 PARK OFFICES DRIVE, SUITE 200, , RESEARCH TRIANGLE PARK, NC, 27709.
Over the last 7 years, insiders at G1 Therapeutics Inc have traded over $53,962,020 worth of G1 Therapeutics Inc stock and bought 1,541,753 units worth $24,259,954 . The most active insiders traders include Capital Management, L.P.Ra ..., Fredric N Eshelman és Glenn P Muir. On average, G1 Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of $198,620. The most recent stock trade was executed by Andrew Perry on 5 July 2024, trading 1,337 units of GTHX stock currently worth $3,356.
g1 therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. the company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates.
G1 Therapeutics Inc executives and other stock owners filed with the SEC include: